Related by context. All words. (Click for frequent words.) 67 oncologic outcomes 67 thoracoscopic lobectomy 66 nephron sparing surgery 66 stratifying patients 66 percutaneous biopsy 66 renal tumors 66 medically inoperable 65 MitraClip device 65 carotid endarterectomy CEA 65 AFRS TM 65 hepatectomy 65 postoperative chemotherapy 65 neoadjuvant therapy 65 cytoreductive surgery 64 perioperative morbidity 64 spinal metastases 64 liver resection 64 EUS FNA 64 adjuvant radiation 64 percutaneous vertebroplasty 64 colorectal cancer liver metastases 64 underwent resection 64 core needle biopsy 64 chemoradiotherapy 64 angiography CTA 64 sacral nerve stimulation 64 concurrent chemoradiation 64 fundoplication 64 Radical prostatectomy 64 colorectal liver metastases 64 benign nodules 64 conventional coronary angiography 64 preoperative diagnosis 64 FDG-PET/CT 63 Adjuvant chemotherapy 63 Surgical resection 63 malignant ascites 63 pancreatic adenocarcinoma 63 extrapleural pneumonectomy 63 cerebral angiography 63 pelvic lymphadenectomy 63 prospective multicenter study 63 osteoporotic compression fractures 63 parathyroidectomy 63 carotid artery stenting CAS 63 conventional angiography 63 pelvic ultrasound 63 skeletal metastases 63 duplex ultrasonography 63 Hepatocellular Carcinoma HCC 63 allogeneic HSCT 63 EBUS FNA 63 arthrography 63 spiral computed tomography 63 HoLEP 63 urothelial cancer 63 riociguat 63 TTF Therapy 63 carotid artery stenting 63 adjuvant radiotherapy 63 carotid artery blockage 63 invasive lobular carcinoma 63 LHRH receptor positive 63 #F FDG PET 62 postoperative morbidity 62 acetabular fractures 62 percutaneous drainage 62 patients undergoing noncardiac 62 hepatic arterial 62 adjuvant therapies 62 randomized Phase IIb 62 adjuvant colon cancer 62 recurrent glioblastoma multiforme 62 myocardial revascularization 62 cytoreduction 62 antiangiogenic agent 62 paclitaxel eluting stents 62 multicenter trials 62 recurrent metastatic 62 ACUITY trial 62 smoldering multiple myeloma 62 Cryoablation 62 nonoperative 62 thymectomy 62 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 62 HIPEC 62 clinically localized prostate 62 carotid stenting 62 Cardiac catheterization 62 myocardial viability 62 Coronary artery bypass 62 unresectable tumors 62 carotid stenosis 62 postoperative mortality 62 leiomyomas 62 localized prostate 62 curative resection 62 neoadjuvant treatment 62 debulking surgery 62 ovarian malignancy 62 catheter angiography 62 endometrial biopsy 62 decompressive surgery 62 antireflux surgery 62 malignant pleural mesothelioma 61 ZOLINZA 61 axillary dissection 61 Surgical excision 61 MRgFUS 61 WallFlex Biliary RX 61 bowel resection 61 elective PCI 61 MDCT angiography 61 atherosclerotic renal artery stenosis 61 oncological outcomes 61 endoluminal 61 STRIDE PD 61 Golimumab 61 Computed tomography 61 Vascular Wrap 61 tumor excision 61 PROCHYMAL 61 esophagectomy 61 TKAs 61 lymphadenectomy 61 lumbar disk herniation 61 CYPHER Stent 61 perfusion defects 61 CBLC# 61 antithrombotic therapy 61 recurrent glioblastoma 61 unicompartmental knee arthroplasty 61 endoscopic resection 61 laparoscopic nephrectomy 61 needle aspiration 61 operable breast cancer 61 chemoembolization 61 postoperative complication 61 radiation therapy SBRT 61 AGHD 61 pediatric malignancies 61 radical nephrectomy 61 intra arterial chemotherapy 61 renal cell carcinomas 61 antibiotic regimens 61 gynaecologic 61 fine needle aspiration 61 PROLARIS 61 abdominal hysterectomy 61 prostate TURP 60 radioiodine therapy 60 COR Analyzer 60 lung resection 60 malignant neoplasm 60 intracranial stenosis 60 QuadraSphere 60 peritoneal cancer 60 preoperative chemotherapy 60 histopathologic examination 60 p# biomarker 60 TOGA procedure 60 carotid artery stenosis 60 tumor resection 60 chemoradiation therapy 60 defibrillator implant 60 sonographic diagnosis 60 Mitral valve repair 60 nonsurgical treatments 60 radiochemotherapy 60 Zybrestat 60 liver biopsies 60 microwave hyperthermia 60 stereotactic radiotherapy 60 cardiac revascularization 60 pathologic diagnosis 60 ruxolitinib 60 osteoporotic vertebral compression fractures 60 esophagogastric 60 noninvasive outpatient 60 Zevalin consolidation 60 pulmonary artery banding 60 portal vein thrombosis 60 prospective nonrandomized 60 localized renal 60 Xelox 60 subgroup analyzes 60 VATS lobectomy 60 rtPA 60 pancreatic islet cell 60 coronary CTA 60 adenomatous 60 liver metastasis 60 pelvic malignancies 60 BETAS 60 coronary stenting 60 spontaneous regression 60 Accelerated Partial Breast Irradiation 60 prognostic indicators 60 CT angiography CTA 60 pulmonary angiography 60 ablative therapy 60 Radiofrequency ablation 60 Carotid endarterectomy 60 R0 resection 60 cystectomy 60 cardiac perfusion 60 arterial revascularization 60 sentinel node biopsy 60 Cystoscopy 60 diagnostic angiography 60 locoregional recurrence 60 recurrent malignant glioma 60 radical prostatectomy RP 60 ALA PDT 60 intravesical therapy 60 genomic biomarker 60 metastatic HRPC 60 enzastaurin 60 metastatic lesions 60 DHEA supplementation 60 relapsed MM 60 oral anticoagulation 60 NEUVENGE 60 excisional biopsy 60 upper endoscopy 60 transesophageal echocardiography 60 sentinel lymph node biopsy 60 meniscectomy 60 bone marrow aspiration 60 epidural steroid injection 60 gadolinium enhanced 60 vaginal hysterectomy 60 Islet transplantation 60 coronary blockages 60 radiographic outcomes 60 diagnostic modality 60 EchoCRT 60 prostate cancer metastases 60 differentiated thyroid 60 BrachySil TM 60 artery stenosis 60 arteriography 60 galiximab 60 perioperative complications 60 nodal metastasis 60 transvaginal sonography 60 treating cancerous tumors 60 transthoracic 60 extracranial 60 wedge resection 60 prostate carcinoma 60 neoadjuvant 60 transient elastography 60 patients undergoing CABG 60 LAGB 60 pCR 60 nephrectomies 60 CARE HF 60 cervical lymph nodes 60 laparoscopically assisted 60 tumor histology 60 cediranib 60 transabdominal 60 MTWA testing 60 Colon polyps 60 lung nodule 60 resectable pancreatic cancer 60 prophylactic cranial irradiation 60 immunosuppressive regimen 60 pseudoaneurysm 60 KRAS status 60 biliary tree 60 Breast conserving 60 motesanib 60 curative therapy 59 LNG IUS 59 histologic examination 59 bone density measurements 59 PRIMO CABG 59 Doxil ® 59 neoadjuvant setting 59 nonoperative treatment 59 multidetector row 59 prospectively stratified 59 transarterial 59 histologic diagnosis 59 sonographically guided 59 peritoneal carcinomatosis 59 olaparib 59 palliative radiotherapy 59 urine cytology 59 biliary tract cancer 59 fluoroscopically guided 59 mediastinoscopy 59 lymph node dissection 59 undergone radical prostatectomy 59 ADAGIO study 59 recurrent NSCLC 59 HER2 positive cancers 59 histologically confirmed 59 antimicrobial prophylaxis 59 Venous thromboembolism 59 CTAP# Capsules 59 Phase #/#a trial 59 MYDICAR 59 percutaneous intervention 59 valve implantation 59 everolimus eluting stents 59 hepatic resection 59 NATRECOR ® 59 Postoperatively 59 intraperitoneal chemotherapy 59 BEXXAR therapeutic regimen 59 pacemaker implantation 59 Carotid Revascularization Endarterectomy vs. 59 F FDG PET 59 Oncotype 59 RF ablation 59 thymoma 59 mucinous 59 laparoscopic fundoplication 59 intraoperative complications 59 ganetespib 59 treating uterine fibroids 59 AA Amyloidosis 59 subconjunctival injection 59 pancreatectomy 59 colonoscopic 59 anti angiogenic therapy 59 ZACTIMA 59 multivessel disease 59 postoperative radiotherapy 59 preoperative MRI 59 angiographic outcomes 59 undergoing cardiac catheterization 59 Enzastaurin 59 hyperplastic polyps 59 cranial radiation 59 antiangiogenic therapy 59 phase IIb study 59 relapsing remitting MS RRMS 59 aromatase inhibitor therapy 59 HER2 expression 59 colon resection 59 metastatic adenocarcinoma 59 osteoid osteoma 59 PET CT scanning 59 ACTEMRA TM 59 underwent surgical resection 59 adrenalectomy 59 cervical fusion 59 transrectal ultrasound guided 59 AVERROES 59 bone marrow biopsies 59 oral ridaforolimus 59 clinicopathologic 59 guided percutaneous 59 transcatheter aortic valve implantation 59 hematopoietic cancers 59 pancreatic lung 59 invasive angiography 59 abdominal ultrasound 59 thyroid nodules 59 MAGE A3 ASCI 59 prostate cancer PCa 59 histological diagnosis 59 Balloon sinuplasty 59 revascularization procedures 59 Flexible sigmoidoscopy 59 less invasive laparoscopic 59 lymph node removal 59 pain palliation 59 symptomatic carotid stenosis 59 nephrectomy 59 Zemplar Capsules 59 urothelial carcinoma 59 metastatic liver 59 excisional 59 degenerative spondylolisthesis 59 unicompartmental knee 59 invasive coronary angiography 59 ClosureFAST 59 Sentinel Lymph Node Biopsy 59 seminoma 59 ductal lavage 59 ICD implantation 59 papillary renal cell carcinoma 59 metastatic GIST 59 CIN2 + 59 Hormonal therapy 59 surgical biopsies 59 ER CHOP 59 hepatorenal syndrome 59 BEXXAR Therapeutic Regimen 59 histopathologic findings 59 chemopreventive agent 59 LVNC 59 Bezielle 59 transurethral resection 59 metastatic lung cancer 59 ablation therapy 59 pre operatively 59 epithelial tumors 59 BoNTA 59 prostate carcinomas 59 laparoscopic colon 59 renal biopsy 59 uterine fibroid 59 polyp detection 59 angiographically 59 Combo Stent 59 PSA nadir 59 pulmonary metastases 59 metastatic neuroendocrine tumors 59 Carotid artery 59 endoscopic retrograde 59 relapsed ALL 59 Sentinel node biopsy 59 SilverHawk Plaque Excision System 59 chronic thromboembolic pulmonary 59 PITX2 methylation 59 epicardial ablation 59 Cystectomy 59 transrectal ultrasound 59 plain radiographs 59 Electronic Brachytherapy 59 squamous cell lung cancer 59 radiotherapy RT 59 transesophageal 59 metastatic bladder 59 metastatic RCC 59 PCI ExTRACT TIMI 59 immunohistochemical 59 coronary arteriography 59 ToGA 58 ultrasonographic examination 58 SCD HeFT 58 Virtual colonoscopy 58 ExTRACT TIMI 58 DVT prophylaxis 58 rt PA 58 metastatic malignant melanoma 58 autologous hematopoietic stem cell 58 anti angiogenic agents 58 Endoscopic Ablation System 58 Carotid stenting 58 gastrointestinal stromal tumors GIST 58 Liver transplantation 58 focal cryoablation 58 endoscopic ultrasonography 58 perioperative mortality 58 androgen suppression therapy 58 Mitomycin C 58 histologic findings 58 KRAS mutations occur 58 OPCAB 58 intracavitary 58 ELACYT 58 core needle biopsies 58 hip resurfacing arthroplasty 58 carcinoid tumor 58 aromatase inhibitors AIs 58 prostate cancer CaP 58 thoracic aortic 58 TRUS biopsy 58 Hurthle cell 58 transplantation HCT 58 laparoscopic radical prostatectomy 58 allogeneic hematopoietic stem cell 58 subcutaneous PRO 58 Coronary Artery Bypass Graft 58 adnexal masses 58 HIV HCV coinfected 58 IV bisphosphonates 58 MSCT 58 LV dysfunction 58 facial transplantation 58 Dr. Cliby 58 BR.# 58 gastroesophageal junction 58 endovascular coiling 58 functional endoscopic sinus 58 bone scintigraphy 58 NSABP C 58 hypervascular tumors 58 Randomized clinical trials 58 epidural steroid injections 58 resectable 58 GnRH agonists 58 neoadjuvant chemotherapy 58 pancreatic cyst 58 acute aortic dissection 58 OnDose TM 58 CINQUIL 58 ductal adenocarcinoma 58 Vascugel ® 58 thoracic aortic aneurysms 58 intraductal 58 Stereotactic Body Radiation Therapy 58 femoral neck fractures 58 intestinal metaplasia 58 β blockers 58 cranial irradiation 58 bronchogenic carcinoma 58 unstable angina UA 58 node dissection 58 preoperative staging 58 repigmentation 58 colon rectal 58 coronary artery bypass grafts 58 histological subtype 58 chest radiographs 58 neurologic outcomes 58 Allovectin 7 ® 58 relapsed SCLC 58 axillary lymph node dissection 58 histologic subtype 58 thrombus aspiration 58 revascularization procedure 58 deCODE ProstateCancer TM 58 BRIM2 58 sternal closure 58 bilateral orchiectomy 58 mg/m2 cohort 58 morphometric vertebral fractures 58 perfusion imaging 58 micrometastasis 58 Coronary angiography 58 HORIZONS AMI trial 58 carotid artery stent 58 treated nonsurgically 58 CYPHER R Sirolimus eluting 58 endothelial keratoplasty 58 conformal radiotherapy 58 TroVax ® 58 multimodality therapy 58 randomized multicenter trial 58 liver biopsy 58 pretransplant 58 SLNB 58 Src inhibitors 58 assessing T DM1 58 immunohistochemical staining 58 biochemical relapse 58 cytoreductive nephrectomy 58 T1c 58 radical cystectomy 58 investigational therapies 58 intravenous bisphosphonates 58 MMP inhibitors 58 surgical revascularization 58 chemoprevention trials 58 EBUS 58 coronary artery stenting 58 esophageal perforation 58 Ophena TM 58 NovoTTF 58 androgen ablation 58 varicoceles 58 basal cell carcinoma BCC 58 surgical resection cavity 58 Duodenal 58 histological examination 58 VADT 58 elacytarabine 58 nonsurgical treatment 58 rFVIIa 58 endobronchial 58 refractory angina 58 pancreatic resection 58 Kidney transplantation 58 pathologic examination 58 PLX STROKE targeting 58 BladderChek 58 AF ablation 58 salpingo oophorectomy 58 FinESS 58 helical CT 58 metastatic pancreatic 58 carotid revascularization 58 androgen deprivation 58 immunosuppressive regimens 58 urethral stricture 58 randomized controlled trials RCTs 58 carotid angioplasty 58 postprocedure 58 #F FDG 58 mitral valve replacement 58 diagnostic biomarker 58 haematologic 58 PROSTVAC TM 58 Circulating tumor cells 58 hepatic metastases 58 lymph node biopsies 58 uterine fibroid embolization 58 FOLPI 58 pulmonary toxicity 58 psoriatic arthritis PsA 58 Trofex 58 ImmuKnow assay 58 refractory metastatic 58 postsurgical 58 IRX 2 58 thalidomide Thalomid 58 Relapsing Remitting MS 58 partial meniscectomy 58 ischemic cardiomyopathy 58 pharmacologic stress 58 samalizumab 58 cerebral vasospasm 58 mutated BRAF gene 58 nonrandomized 58 cryosurgery 58 cartilage lesions 58 nodal dissection 58 balloon valvuloplasty 58 MGd 58 IMPACT DCM 58 bladder tumors 58 trial evaluating PRX# 58 Vertebroplasty 58 Heavy menstrual bleeding 58 anti angiogenic drugs 58 visceral metastases 58 Tumor Response 58 antiretroviral naïve 58 transfemoral approach 58 Coronary artery bypass graft 58 surgical debulking 58 carotid stents 58 transfemoral 58 cystic lesions 58 MADIT II 58 endovascular repair 58 directed thrombolysis 58 radiographic findings 58 randomized blinded 58 neuroendocrine cancers 58 digital subtraction angiography 58 lymphatic mapping 58 lumbar fusion 58 breast conserving lumpectomy 58 KRAS mutation 58 postoperative atrial fibrillation 58 NMIBC 57 hamartomas 57 thymic carcinoma 57 recurrent GBM 57 esophageal gastric 57 Endoscopic ultrasound 57 antitumor effect 57 dose escalation phase 57 hypofractionated radiation 57 engineered bladders 57 neovascular diseases 57 Scheuermann kyphosis 57 CTEPH 57 frameless radiosurgery 57 liver transplant recipients 57 biopsy specimens 57 nonpharmacologic 57 SPIRIT FIRST 57 teriflunomide 57 precursor lesions 57 remnant ablation 57 enucleation 57 Lung transplantation 57 Computed tomographic 57 cervical lymph node 57 colorectal lung 57 vertebral compression fractures 57 defibrillator implantation 57 keratoplasty 57 Arteriovenous 57 XIENCE V stent 57 Coronary artery bypass grafting 57 Subgroup analysis 57 Novartis Zometa 57 sympathectomy 57 urodynamic 57 total thyroidectomy 57 nonischemic 57 clevidipine 57 variceal bleeding 57 nodal metastases 57 Coronary CTA 57 ovarian carcinoma 57 radiofrequency ablation RFA 57 dosage regimens 57 Vicinium TM 57 symptomatic paroxysmal AF 57 Plain radiographs 57 thromboprophylaxis 57 Edwards SAPIEN valve 57 radiation sensitizer 57 recanalization 57 repair TEVAR 57 Screening Trial DMIST 57 axitinib 57 gynecologic procedures 57 computed tomography scans 57 hepatic lesions 57 EVEREST II 57 endovascular procedures 57 surgical excision 57 tricuspid regurgitation 57 HuMax EGFr 57 orchiectomy 57 TheraSphere 57 zalutumumab 57 posttraumatic arthritis 57 symptomatic fibroids 57 kidney urologic 57 ImmuKnow 57 allogeneic transplant 57 GEM OS1 57 TEVAR 57 FDG PET CT 57 PROactive study 57 Angiograms 57 SIR Spheres 57 5-fluorouracil/leucovorin 57 troponins 57 extracolonic findings 57 benign prostatic hyperplasia enlarged 57 precancerous condition 57 transfusion syndrome 57 methotrexate therapy 57 standard chemotherapy regimens 57 biliary tract cancers 57 scintigraphic 57 VCUG 57 postmenopausal hormones 57 CIMZIA TM certolizumab pegol 57 sleeve lobectomy 57 TAXUS Liberte Stent 57 histopathologic 57 chemo resistant 57 gastric corpus 57 SIADH 57 VerifyNow 57 venography 57 NeuroFlo 57 Digital Mammographic Imaging 57 SYNTAX trial 57 perforated appendicitis 57 IV NSCLC 57 Tavocept 57 flavopiridol 57 preoperative radiotherapy 57 RECIST Response Evaluation Criteria 57 confirmatory clinical 57 MAL PDT 57 fosbretabulin 57 colorectal adenocarcinoma 57 post thrombotic syndrome 57 eculizumab therapy 57 ImmunoVEX HSV2 57 AVOREN 57 sirolimus eluting stents 57 polidocanol 57 rALLy 57 plasminogen activators 57 deep venous thromboses 57 endometrial hyperplasia 57 RX Acculink 57 stem cell transplantations 57 renal denervation 57 orchidectomy 57 aortic insufficiency 57 iniparib 57 hsCRP levels 57 PSADT 57 body contouring procedure 57 histologically proven 57 benign neoplasms 57 methotrexate monotherapy 57 underwent coronary angiography 57 tricuspid valve repair 57 deCODE BreastCancer TM 57 antibiotic prophylaxis 57 GIST tumors 57 candidemia 57 deferiprone 57 esophageal resection 57 testosterone supplementation 57 allogeneic transplants 57 drug eluting stent implantation 57 endovascular therapy 57 antitumor efficacy 57 radiotherapy chemotherapy 57 perioperatively 57 Alocrest 57 bovine thrombin 57 eTag assays 57 fallopian tube cancers 57 SERCA2a 57 forodesine 57 abdominal pelvic 57 BRAF inhibitor 57 Umbilical cord stem cells 57 BRAF V# mutation 57 Radio Frequency Ablation 57 IORT 57 adjuvant systemic 57 alvespimycin 57 noninvasive imaging 57 MiCK assay 57 Gleevec resistant 57 lumbar spinal fusion 57 oral clodronate 57 FDG PET 57 PFO migraine 57 sonographically 57 radiofrequency ablation 57 TAXUS IV 57 CUSTOM III 57 computed tomographic 57 replacement TAVR 57 haematological cancers 57 Randomized trials 57 allogeneic hematopoietic cell 57 hereditary deficiency 57 tumor necrosis 57 Targretin capsules 57 prescribe statins 57 robotically assisted 57 pathologic correlation 57 briakinumab 57 ADVEXIN therapy 57 RALP 57 diagnosing coronary artery 57 aortic valve stenosis 57 HNSCC 57 Oncotype DX colon cancer 57 mitral regurgitation MR 57 superficial bladder cancer 57 myelofibrosis MF 57 immunohistochemical analysis 57 Kyphoplasty 57 balloon brachytherapy 57 Hydroxyurea 57 Stenting Trial CREST 57 femoral neck fracture 57 carcinoid tumors 57 coronary computed tomography 57 ReN# therapy 57 renal artery stenting 57 MyVax personalized immunotherapy 57 hemostatic efficacy 57 angioplasty stenting 57 VTE prophylaxis 57 prophylactic oophorectomy 57 intensive statin therapy 57 primary hyperparathyroidism 57 myoma 57 aerosolized KL4 surfactant 57 potentially cancerous polyps 57 lymphomas leukemias 57 minimal invasiveness 57 Subgroup analyzes 57 autologous transplants 57 clinico pathological 57 IOP lowering 57 laparoscopic colectomy 57 Pseudomonas aeruginosa infections 57 thromboembolic disease 57 pituitary adenomas 57 pT2 57 strontium ranelate 57 intravenous diuretics 57 Lymph node 57 Augment Injectable 57 DCVax Brain 57 photocoagulation 57 recurrent ovarian 57 graft occlusion 57 oncologic 57 nonrandomized studies 57 fluorodeoxyglucose positron emission tomography 57 ablation procedures 57 acetabular dysplasia 57 radioimmunotherapy RIT 57 resections 57 thrombotic complications 57 FOLFOX4 57 CT angiogram 57 incomplete revascularization 57 nonalcoholic steatohepatitis NASH 57 cisplatin resistant 57 arthroplasties 57 sputum cytology 57 functional mitral regurgitation 57 recurrent myocardial infarction 57 Mohs micrographic surgery 57 intravenous cyclophosphamide 57 invasive ductal breast cancer 57 reoperations 57 Alessandro Riva 57 prospectively enrolled 57 computerized tomography scans 57 HBV infections 57 BRIM3 57 anagrelide 57 Renal Cell Carcinoma RCC 57 carotid surgery 57 colonography 57 bronchoscopic procedure 57 undergoing hysterectomy 57 relapsed ovarian cancer 57 DASISION 57 Proxinium TM 57 lobectomies 57 refractory ovarian cancer 57 sonographic findings 57 Group RTOG 57 oral rivaroxaban 57 Histologic 57 IVTA 57 TLIF 57 VTE prevention 57 Corus CAD 57 docetaxel Taxotere ® 57 percutaneous interventions 57 kidney cysts 57 Azedra 57 Capsule endoscopy 57 ongoing Phase 1b 57 revascularisation 57 radical retropubic prostatectomy 57 pertuzumab 57 CYT# potent vascular disrupting 57 coronary CT angiography 57 mycophenolate mofetil 57 leukemia multiple myeloma 57 GEM OS2 57 NAVISTAR R 57 clot busting therapy 57 ATIR 57 pelvic radiotherapy 57 bile duct cancers 56 narrowed carotid arteries 56 osteoarthritic 56 DEXA scans 56 prostate cancer CRPC 56 laparoscopic cholecystectomy 56 K ras mutations 56 lumbar disc herniation 56 aldosterone antagonists 56 discogenic pain 56 ConclusionThis 56 endoscopic ultrasound 56 prognostically 56 percutaneous nephrolithotomy 56 phakic 56 SBRT 56 zotarolimus 56 colorectal carcinoma 56 Advagraf 56 percutaneous ablation 56 rALLy trial 56 OncoVEX GM CSF 56 cosmesis 56 crizotinib PF # 56 Edwards SAPIEN transcatheter 56 gefitinib Iressa 56 interstitial brachytherapy 56 ovarian suppression 56 epithelial ovarian 56 B7 H3 56 lenalidomide Revlimid R 56 Diamondback #deg 56 underwent radical cystectomy 56 chronic GVHD 56 paracentesis 56 carcinoid 56 PNH patients 56 Histopathologic examination 56 HER2 amplified 56 surgically resectable 56 RTOG 56 fluoroscopy guided 56 Velcade bortezomib 56 renal artery stenosis 56 sacrocolpopexy 56 Postoperative complications 56 myelodysplastic myeloproliferative diseases 56 flurpiridaz F 56 resynchronization therapy 56 DCVax R 56 myocardial reperfusion 56 postoperative infection 56 Telatinib 56 transcervical 56 endoscopists 56 imaging modality 56 ureteroscopy 56 basal cell cancers 56 diagnosed prenatally